The future of medicine is going to change in massive ways in the next few years. Besides COVID-19, technology will be one of the driving factors of that.
Jo Bhakdi is the Founder & Chief Executive Officer is the founder and CEO of Quantgene, which unlocks the Deep Human Genome by building and deploying the world’s leading Deep Genomics solution.
He talks this episode about machine learning, sequencing technology, longevity, and the "era of precision medicine."
Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. - sponsor
Bonus
How Your Diet Affects Your Risk for Cancer
Featuring:
Jo Bhakdi
Jo Bhakdi is the Founder & Chief Executive Officer is the founder and CEO of Quantgene. His work in machine learning, sequencing technology, and DNA extraction procedures defines the cutting edge of genomic diagnostics, early disease detection, and precision medicine.Prior to Quantgene, Jo founded i2X, an investment framework that composes low-risk Venture Capital portfolios across large numbers of technology startups. The i2X platform laid important foundations for advanced analytics in both financial and biotechnology applications, such as the Quantgene machine learning platform. Bhakdi holds a Masters in Economics and Psychology from Tubingen University, one of Germany’s leading academic institutions, with a focus on financial theory and statistics. He kicked off his career at WPP and Omnicom, where he held Strategy and Executive Director positions. Beyond his focus on technology and the future of medicine, Bhakdi is dedicated to bringing together the best and brightest and transforming them into pioneers, pushing the boundaries of health, life, and innovation for all.
